MedPath

PHL-SIMVASTATIN

PHL-SIMVASTATIN

Discontinued
DIN Number

02253720

Drug Class

Human

Market Date

Aug 11, 2004

Company
HC

pharmel inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02253720
AIG Number0122415002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AA01 SIMVASTATIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:06.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

SIMVASTATINActive
Strength: 40 MG
Monograph: SIMVASTATIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.